Drug Shortage Report for TEVA-MEDROXYPROGESTERONE

Last updated on 2020-07-30 History
Report ID 121497
Drug Identification Number 02221292
Brand name TEVA-MEDROXYPROGESTERONE
Common or Proper name MEDROXYPROGESTERONE 5MG TABS
Company Name TEVA CANADA LIMITED
Market Status MARKETED
Active Ingredient(s) MEDROXYPROGESTERONE ACETATE
Strength(s) 5MG
Dosage form(s) TABLET
Route of administration ORAL ORAL
Packaging size 100
ATC code G03DA
ATC description PROGESTOGENS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2020-07-29
Estimated end date 2021-02-28
Actual end date
Shortage status Actual shortage
Updated date 2020-07-30
Company comments
Health Canada comments
Contact Address 30 NOVOPHARM COURT
TORONTO, ONTARIO
CANADA M1B 2K9
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v2 2020-07-30 French Compare
v1 2020-07-30 English Compare